Australian rural program to get Aus$10m for medical technology:
This article was originally published in Clinica
Australia is to provide its Rural Private Access Program with medical grants worth Aus$10m (US$7m) for a range of equipment and services. Rural private hospitals and medical services will obtain: operating theatre equipment (such as anaesthetic monitors); intensive care units; mobile physiotherapy services; renal dialysis; rehabilitation services; training; and speech pathology outreach services. The four-year, Aus$36m programme is part of the country's rural health strategy. It aims to improve private health facilities and the range of privately insurable health services in rural and remote areas.
You may also be interested in...
ConMed Corp. is company of two halves ̶ general surgery and orthopedics – and is readying itself for a renewed assault on these two markets on the back of a technology pipeline, targeted acquisitions and a new growth-winning culture, says CFO Todd Garner.
Drug pricing and access issues expose the pharmaceutical sector especially acutely to calls for companies to meet ethical and social goals, alongside commercial ones. Digital is up-ending pharma’s processes, its workplaces and its consumers. R&D productivity is spluttering. Amid this turmoil, CEOs highlight company culture – the way an organization behaves – as a crucial ingredient for success. But what is a “right” culture? Organizational culture is neither static nor singular. It is continuously influenced by acquisitions, markets, new technologies and new generations. And pharma’s history suggests that culture change cannot happen without sufficient people change.